Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug

Journal of Biomaterials Science. Polymer Edition
Liyan ShiHua Zheng

Abstract

In this paper, a kind of glutathione-sensitive polymeric micelles was prepared through assembling in aqueous solution of an amphiphilic polymeric prodrug which was synthesized by linkage of 6-mercaptopurine (6-MP) and polyethylene glycol monomethyl ether using propiolic acid as a connecting arm. The glutathione (GSH)-sensitive strategy is based on a Michael addition-elimination reaction, that is the amphiphilic polymeric prodrug which contains α, β-unsaturated carbonyl group acts as a Michael acceptor to receive the attack of nucleophile - glutathione, and undergoes elimination reaction to release the original drug. Transmission electron microscope observation showed that the polymeric micelles (PMs) had a spherical-like morphology with a mean diameter of 28 ± 3.2 nm. The dynamic light scattering investigation data exhibited that the size and distribution changes of PMs are negligible after being placed for 15 days. In vitro drug release study indicated that only less than 13% of 6-MP was released from the micelles under GSH stimulation at micromolar level, while 34.5, 53.7, and 77.8% accumulative release rates were achieved under GSH stimulation at millimolar level (1, 2 and 10 mM), respectively. The cell inhibition rate of PM...Continue Reading

References

Jan 1, 1992·European Journal of Clinical Pharmacology·L Lennard
Jan 1, 1983·Annual Review of Biochemistry·A Meister, M E Anderson
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sjofn GunnarsdottirAdnan A Elfarra
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Nov 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Geneviève GaucherJean-Christophe Leroux
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Sep 6, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Alisar S ZahrMichael V Pishko
Jul 14, 2007·Advanced Drug Delivery Reviews·Valentino J Stella, Kwame W Nti-Addae
Oct 9, 2007·Bioorganic & Medicinal Chemistry Letters·Marina ZacchignaSara Drioli
Apr 10, 2008·Journal of the American Chemical Society·Seiji TakaeKazunori Kataoka
Aug 5, 2008·Molecular Pharmaceutics·Frank AlexisOmid C Farokhzad
Aug 13, 2009·Advanced Drug Delivery Reviews·Gianfranco Pasut, Francesco M Veronese
Feb 22, 2011·Advanced Drug Delivery Reviews·Rubi MahatoKun Cheng
Sep 5, 2012·International Journal of Pharmaceutics·Ying Lu, Kinam Park
Sep 8, 2012·Molecular Pharmaceutics·André J van der VliesJeffrey A Hubbell
Feb 7, 2013·Colloids and Surfaces. B, Biointerfaces·Qinge WuShiyuan Liu
Jun 9, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Hui-Kang Yang, Li-Ming Zhang
Jul 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Atul KolateAmbikanandan Misra
Dec 3, 2014·Trends in Pharmacological Sciences·Cong LuoZhonggui He
Mar 31, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Edgar Pérez-Herrero, Alberto Fernández-Medarde

❮ Previous
Next ❯

Methods Mentioned

BETA
dynamic light scattering
fluorescence spectroscopy

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.